CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle and the vasculature today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron will provide a corporate presentation at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 at 4:30 PM (EDT). The conference will be held at the Grand Hyatt Hotel in New York City.
